vs
OCEANEERING INTERNATIONAL INC（OII）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
OCEANEERING INTERNATIONAL INC的季度营收约是Royalty Pharma plc的1.1倍（$692.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.2%，领先29.2%），Royalty Pharma plc同比增速更快（4.8% vs 3.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.8%）
奥什科什国际（Oceaneering International）是一家总部位于美国得克萨斯州休斯敦的水下工程及应用技术企业，为海洋、航天及其他特殊作业场景的客户提供定制化工程服务与硬件设备，在极端环境工程领域拥有深厚的技术积累。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
OII vs RPRX — 直观对比
营收规模更大
OII
是对方的1.1倍
$622.0M
营收增速更快
RPRX
高出1.2%
3.6%
净利率更高
RPRX
高出29.2%
5.2%
两年增速更快
RPRX
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $692.4M | $622.0M |
| 净利润 | $36.1M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 5.2% | 34.4% |
| 营收同比 | 3.6% | 4.8% |
| 净利润同比 | -28.3% | 2.9% |
| 每股收益（稀释后） | $0.36 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OIIRPRX
| Q1 26 | $692.4M | — | ||
| Q4 25 | $668.6M | $622.0M | ||
| Q3 25 | $742.9M | $609.3M | ||
| Q2 25 | $698.2M | $578.7M | ||
| Q1 25 | $674.5M | $568.2M | ||
| Q4 24 | $713.5M | $593.6M | ||
| Q3 24 | $679.8M | $564.7M | ||
| Q2 24 | $668.8M | $537.3M |
净利润OIIRPRX
| Q1 26 | $36.1M | — | ||
| Q4 25 | $177.7M | $214.2M | ||
| Q3 25 | $71.3M | $288.2M | ||
| Q2 25 | $54.4M | $30.2M | ||
| Q1 25 | $50.4M | $238.3M | ||
| Q4 24 | $56.1M | $208.2M | ||
| Q3 24 | $41.2M | $544.0M | ||
| Q2 24 | $35.0M | $102.0M |
毛利率OIIRPRX
| Q1 26 | — | — | ||
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.6% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 19.3% | — | ||
| Q2 24 | 18.0% | — |
营业利润率OIIRPRX
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 62.4% | ||
| Q3 25 | 11.6% | 70.1% | ||
| Q2 25 | 11.3% | 36.3% | ||
| Q1 25 | 10.9% | 94.0% | ||
| Q4 24 | 10.9% | 60.9% | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 9.0% | 50.2% |
净利率OIIRPRX
| Q1 26 | 5.2% | — | ||
| Q4 25 | 26.6% | 34.4% | ||
| Q3 25 | 9.6% | 47.3% | ||
| Q2 25 | 7.8% | 5.2% | ||
| Q1 25 | 7.5% | 41.9% | ||
| Q4 24 | 7.9% | 35.1% | ||
| Q3 24 | 6.1% | 96.3% | ||
| Q2 24 | 5.2% | 19.0% |
每股收益（稀释后）OIIRPRX
| Q1 26 | $0.36 | — | ||
| Q4 25 | $1.75 | $0.49 | ||
| Q3 25 | $0.71 | $0.67 | ||
| Q2 25 | $0.54 | $0.07 | ||
| Q1 25 | $0.49 | $0.55 | ||
| Q4 24 | $0.55 | $0.46 | ||
| Q3 24 | $0.40 | $1.21 | ||
| Q2 24 | $0.34 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $488.8M | $9.0B |
| 股东权益账面价值 | $1.1B | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资OIIRPRX
| Q1 26 | — | — | ||
| Q4 25 | $695.9M | $618.7M | ||
| Q3 25 | $7.0M | $938.9M | ||
| Q2 25 | $7.0M | $631.9M | ||
| Q1 25 | $7.0M | $1.1B | ||
| Q4 24 | $504.5M | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务OIIRPRX
| Q1 26 | $488.8M | — | ||
| Q4 25 | $487.4M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $482.0M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益OIIRPRX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $9.7B | ||
| Q3 25 | $907.7M | $9.6B | ||
| Q2 25 | $842.1M | $9.5B | ||
| Q1 25 | $773.1M | $9.8B | ||
| Q4 24 | $714.3M | $10.3B | ||
| Q3 24 | $698.0M | $10.3B | ||
| Q2 24 | $651.0M | $9.8B |
总资产OIIRPRX
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.7B | $19.6B | ||
| Q3 25 | $2.5B | $19.3B | ||
| Q2 25 | $2.3B | $18.3B | ||
| Q1 25 | $2.3B | $17.6B | ||
| Q4 24 | $2.3B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.3B | $17.7B |
负债/权益比OIIRPRX
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.46× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.67× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-76.5M | — |
| 自由现金流率自由现金流/营收 | -11.1% | — |
| 资本支出强度资本支出/营收 | 2.5% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $238.1M | — |
8季度趋势，按日历期对齐
经营现金流OIIRPRX
| Q1 26 | — | — | ||
| Q4 25 | $221.1M | $827.1M | ||
| Q3 25 | $101.3M | $702.6M | ||
| Q2 25 | $77.2M | $364.0M | ||
| Q1 25 | $-80.7M | $596.1M | ||
| Q4 24 | $128.4M | $742.5M | ||
| Q3 24 | $91.9M | $703.6M | ||
| Q2 24 | $52.6M | $658.2M |
自由现金流OIIRPRX
| Q1 26 | $-76.5M | — | ||
| Q4 25 | $190.7M | — | ||
| Q3 25 | $77.0M | — | ||
| Q2 25 | $46.9M | — | ||
| Q1 25 | $-106.8M | — | ||
| Q4 24 | $94.5M | — | ||
| Q3 24 | $67.0M | — | ||
| Q2 24 | $29.8M | — |
自由现金流率OIIRPRX
| Q1 26 | -11.1% | — | ||
| Q4 25 | 28.5% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | -15.8% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 9.9% | — | ||
| Q2 24 | 4.5% | — |
资本支出强度OIIRPRX
| Q1 26 | 2.5% | — | ||
| Q4 25 | 4.6% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 3.4% | — |
现金转化率OIIRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | 3.86× | ||
| Q3 25 | 1.42× | 2.44× | ||
| Q2 25 | 1.42× | 12.06× | ||
| Q1 25 | -1.60× | 2.50× | ||
| Q4 24 | 2.29× | 3.57× | ||
| Q3 24 | 2.23× | 1.29× | ||
| Q2 24 | 1.50× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OII
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
